- Published on
Emergency And Acute Medicine – Deep Vein Thrombosis
Core Description
A constant balance exists between intravascular clot formation and clot dissolution. Thrombosis develops when clot formation overwhelms fibrinolysis. Venous clots may be superficial (above the fascia) or deep; the latter constitutes deep vein thrombosis (DVT). Pulmonary embolism (PE) and DVT represent two ends of the same disease spectrum known as venous thromboembolism (VTE). DVT may involve upper or lower extremities and may be distal or proximal relative to the popliteal vein. The incidence is approximately 2 first-time VTE events per 1,000 person-years, increases with age, and is common among hospitalized medical and surgical patients. Diagnosis is more accurate with active surveillance rather than clinical suspicion alone.
Pediatric Considerations
DVT is uncommon in children. When present, evaluation for underlying hypercoagulable conditions is essential. Upper-extremity DVT in children is frequently associated with central venous catheters.
Etiology And Risk Factors
Thrombus formation is influenced by multiple interacting factors. Hypercoagulable states include malignancy, myeloproliferative disorders, nephrotic syndrome, sepsis, inflammatory conditions such as ulcerative colitis, increased estrogen states including pregnancy and exogenous hormones, antiphospholipid syndrome, inherited thrombophilias (protein C, protein S, antithrombin III deficiencies, factor V Leiden, prothrombin gene mutation), and autoimmune conditions.
Venous stasis occurs with prolonged bed rest, immobilization (casts), long-distance travel, paralysis from neurologic disease, congestive heart failure, and obesity.
Vascular injury or anatomic abnormalities include trauma, surgery, central venous lines (particularly for upper-extremity DVT), and May–Thurner syndrome.
Additional contributors include advanced age, certain medications (hydralazine, procainamide, phenothiazines), tobacco use, prior DVT or PE, and genetic predisposition. There is no universal consensus on which VTE patients require testing for inherited thrombophilias.
Pregnancy And Geriatric Considerations
Pregnancy increases DVT risk, particularly during the third trimester and up to two weeks postpartum. Advanced age independently increases DVT and PE risk, and presentations may be atypical in older adults.
Clinical Features
Typical findings include unilateral leg swelling, with a circumference difference greater than 1 cm considered significant, warmth, erythema, pain, tenderness, and sometimes a palpable cord. Superficial thrombophlebitis may present as a visible, tender, cord-like structure. Upper-extremity DVT causes arm swelling, warmth, and tenderness.
Severe presentations include phlegmasia cerulea dolens, characterized by a cold, tender, swollen, cyanotic limb with secondary arterial insufficiency and venous gangrene, and phlegmasia alba dolens, presenting with a cold, tender, pale limb due to arterial compromise.
Essential Evaluation
Assessment of pretest probability is central to DVT evaluation. Careful history and physical examination interpreted within the patient’s risk-factor profile guide diagnostic decisions, as individual signs and symptoms lack sufficient predictive value. Consider evaluation for occult malignancy when clinically appropriate, as VTE may be its initial manifestation.
Diagnostic Testing And Interpretation
D-dimer testing detects fibrin degradation products and is useful only when negative, allowing exclusion of DVT in low-risk patients. A positive result is nonspecific and mandates further imaging. ELISA-based D-dimer assays are the most validated, particularly when combined with pretest probability assessment.
Compression ultrasonography is the first-line diagnostic modality. Normal veins compress fully, whereas thrombosed veins do not. Duplex ultrasonography, combining B-mode imaging with Doppler, has sensitivity in the high 90% range. In high-risk patients with an initial negative ultrasound, repeat imaging or contrast venography is recommended.
Contrast venography, once the gold standard, is now rarely used because of invasiveness and associated complications. Other modalities such as radionuclide venography and impedance plethysmography are infrequently used.
Differential Diagnosis
Consider superficial thrombophlebitis, cellulitis, muscle or ligament tears, ruptured Baker cyst, bilateral edema from cardiac, hepatic, or renal disease, venous insufficiency, drug-induced edema, unilateral edema from abdominal masses or lymphedema, and postphlebitic syndrome.
Initial Stabilization
In cases of phlegmasia alba or cerulea dolens, establish IV access, administer supplemental oxygen, and obtain urgent vascular or surgical consultation.
Emergency Department Management
Systemic anticoagulation is the cornerstone of therapy in patients without contraindications, as PE develops in approximately 50% of untreated DVT. Options include unfractionated heparin, low-molecular-weight heparin (LMWH), fondaparinux, or adjusted-dose subcutaneous heparin. Carefully selected patients may be managed as outpatients.
Warfarin should be initiated only after heparin therapy to avoid transient hypercoagulability. Current evidence is insufficient to universally recommend newer oral anticoagulants in this setting.
Inferior vena cava filters are indicated when anticoagulation is contraindicated or when thromboembolism occurs despite adequate anticoagulation. Filters may also be considered in select high-risk scenarios, though randomized trials show no superiority over anticoagulation alone. Filters can also be placed in the superior vena cava for upper-extremity DVT.
Thrombolysis is rarely indicated because of increased bleeding risk but may be considered in select cases, particularly catheter-directed therapy for upper-extremity DVT. Thrombectomy may be appropriate for extensive disease after vascular consultation. Septic thrombophlebitis requires antibiotics and may necessitate surgical intervention.
Medication Management
Anticoagulation is continued until the INR is therapeutic for two consecutive days. Typical regimens include unfractionated heparin with a bolus followed by infusion titrated to aPTT, LMWH such as enoxaparin or tinzaparin, and warfarin initiated at standard dosing with INR monitoring. Treatment duration is generally at least three months and individualized thereafter.
Disposition And Follow-Up
Admission is indicated for patients unable to receive outpatient anticoagulation, those with concomitant PE, high bleeding risk, phlegmasia, or serious comorbidities.
Outpatient management is appropriate for reliable patients without serious comorbid disease who can administer LMWH and adhere to follow-up.
Vascular surgery consultation is warranted if arterial insufficiency is suspected or when considering vena cava filter placement.
Follow-Up Recommendations
Patients managed as outpatients require close monitoring of hematocrit, platelet count, and INR within several days. Repeat imaging is recommended when clinical suspicion remains high despite an initial negative ultrasound.
Key Clinical Lessons And Common Errors
A negative Homans sign does not exclude DVT. Always assess pretest probability using clinical judgment or validated tools such as the Wells score. In high-risk patients, proceed directly to imaging rather than relying on D-dimer testing. In moderate-risk patients with negative initial studies, arrange repeat evaluation within one week.
Core Description
A constant balance exists between intravascular clot formation and clot dissolution. Thrombosis develops when clot formation overwhelms fibrinolysis. Venous clots may be superficial (above the fascia) or deep; the latter constitutes deep vein thrombosis (DVT). Pulmonary embolism (PE) and DVT represent two ends of the same disease spectrum known as venous thromboembolism (VTE). DVT may involve upper or lower extremities and may be distal or proximal relative to the popliteal vein. The incidence is approximately 2 first-time VTE events per 1,000 person-years, increases with age, and is common among hospitalized medical and surgical patients. Diagnosis is more accurate with active surveillance rather than clinical suspicion alone.
Pediatric Considerations
DVT is uncommon in children. When present, evaluation for underlying hypercoagulable conditions is essential. Upper-extremity DVT in children is frequently associated with central venous catheters.
Etiology And Risk Factors
Thrombus formation is influenced by multiple interacting factors. Hypercoagulable states include malignancy, myeloproliferative disorders, nephrotic syndrome, sepsis, inflammatory conditions such as ulcerative colitis, increased estrogen states including pregnancy and exogenous hormones, antiphospholipid syndrome, inherited thrombophilias (protein C, protein S, antithrombin III deficiencies, factor V Leiden, prothrombin gene mutation), and autoimmune conditions.
Venous stasis occurs with prolonged bed rest, immobilization (casts), long-distance travel, paralysis from neurologic disease, congestive heart failure, and obesity.
Vascular injury or anatomic abnormalities include trauma, surgery, central venous lines (particularly for upper-extremity DVT), and May–Thurner syndrome.
Additional contributors include advanced age, certain medications (hydralazine, procainamide, phenothiazines), tobacco use, prior DVT or PE, and genetic predisposition. There is no universal consensus on which VTE patients require testing for inherited thrombophilias.
Pregnancy And Geriatric Considerations
Pregnancy increases DVT risk, particularly during the third trimester and up to two weeks postpartum. Advanced age independently increases DVT and PE risk, and presentations may be atypical in older adults.
Clinical Features
Typical findings include unilateral leg swelling, with a circumference difference greater than 1 cm considered significant, warmth, erythema, pain, tenderness, and sometimes a palpable cord. Superficial thrombophlebitis may present as a visible, tender, cord-like structure. Upper-extremity DVT causes arm swelling, warmth, and tenderness.
Severe presentations include phlegmasia cerulea dolens, characterized by a cold, tender, swollen, cyanotic limb with secondary arterial insufficiency and venous gangrene, and phlegmasia alba dolens, presenting with a cold, tender, pale limb due to arterial compromise.
Essential Evaluation
Assessment of pretest probability is central to DVT evaluation. Careful history and physical examination interpreted within the patient’s risk-factor profile guide diagnostic decisions, as individual signs and symptoms lack sufficient predictive value. Consider evaluation for occult malignancy when clinically appropriate, as VTE may be its initial manifestation.
Diagnostic Testing And Interpretation
D-dimer testing detects fibrin degradation products and is useful only when negative, allowing exclusion of DVT in low-risk patients. A positive result is nonspecific and mandates further imaging. ELISA-based D-dimer assays are the most validated, particularly when combined with pretest probability assessment.
Compression ultrasonography is the first-line diagnostic modality. Normal veins compress fully, whereas thrombosed veins do not. Duplex ultrasonography, combining B-mode imaging with Doppler, has sensitivity in the high 90% range. In high-risk patients with an initial negative ultrasound, repeat imaging or contrast venography is recommended.
Contrast venography, once the gold standard, is now rarely used because of invasiveness and associated complications. Other modalities such as radionuclide venography and impedance plethysmography are infrequently used.
Differential Diagnosis
Consider superficial thrombophlebitis, cellulitis, muscle or ligament tears, ruptured Baker cyst, bilateral edema from cardiac, hepatic, or renal disease, venous insufficiency, drug-induced edema, unilateral edema from abdominal masses or lymphedema, and postphlebitic syndrome.
Initial Stabilization
In cases of phlegmasia alba or cerulea dolens, establish IV access, administer supplemental oxygen, and obtain urgent vascular or surgical consultation.
Emergency Department Management
Systemic anticoagulation is the cornerstone of therapy in patients without contraindications, as PE develops in approximately 50% of untreated DVT. Options include unfractionated heparin, low-molecular-weight heparin (LMWH), fondaparinux, or adjusted-dose subcutaneous heparin. Carefully selected patients may be managed as outpatients.
Warfarin should be initiated only after heparin therapy to avoid transient hypercoagulability. Current evidence is insufficient to universally recommend newer oral anticoagulants in this setting.
Inferior vena cava filters are indicated when anticoagulation is contraindicated or when thromboembolism occurs despite adequate anticoagulation. Filters may also be considered in select high-risk scenarios, though randomized trials show no superiority over anticoagulation alone. Filters can also be placed in the superior vena cava for upper-extremity DVT.
Thrombolysis is rarely indicated because of increased bleeding risk but may be considered in select cases, particularly catheter-directed therapy for upper-extremity DVT. Thrombectomy may be appropriate for extensive disease after vascular consultation. Septic thrombophlebitis requires antibiotics and may necessitate surgical intervention.
Medication Management
Anticoagulation is continued until the INR is therapeutic for two consecutive days. Typical regimens include unfractionated heparin with a bolus followed by infusion titrated to aPTT, LMWH such as enoxaparin or tinzaparin, and warfarin initiated at standard dosing with INR monitoring. Treatment duration is generally at least three months and individualized thereafter.
Disposition And Follow-Up
Admission is indicated for patients unable to receive outpatient anticoagulation, those with concomitant PE, high bleeding risk, phlegmasia, or serious comorbidities.
Outpatient management is appropriate for reliable patients without serious comorbid disease who can administer LMWH and adhere to follow-up.
Vascular surgery consultation is warranted if arterial insufficiency is suspected or when considering vena cava filter placement.
Follow-Up Recommendations
Patients managed as outpatients require close monitoring of hematocrit, platelet count, and INR within several days. Repeat imaging is recommended when clinical suspicion remains high despite an initial negative ultrasound.
Key Clinical Lessons And Common Errors
A negative Homans sign does not exclude DVT. Always assess pretest probability using clinical judgment or validated tools such as the Wells score. In high-risk patients, proceed directly to imaging rather than relying on D-dimer testing. In moderate-risk patients with negative initial studies, arrange repeat evaluation within one week.
0 Comments
